Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in Europe
Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in Europe
RELEASE DATE
28-Nov-2004
28-Nov-2004
REGION
Global
Global
Research Code: B484-01-00-00-00
SKU: HC01072-GL-MR_05106
$3,950.00
In stock
SKU
HC01072-GL-MR_05106
Description
This strategic analysis service provides detailed analysis of royalty issues and its affects on pharmaceutical products. The service in powerpoint format (approximately 75 slides) focuses not just only on the problems with royalty stacking, patents and problems with commercialisation of biotechnology but also on strategies for resolution of these problems.
Table of Contents
Overview
- Overview
Research Scope and Methodology
- Research Scope and Methodology
Introduction
- General Introduction and Background
Patent Environment
- Patent Environment
Royalty Stacking Environment
- Royalty Stacking Environment
Solutions to Royalty Stacking
- Solutions to Royalty Stacking
Managing Royalties
- Managing Royalties
Strategic Recommendations
- Strategic Recommendations
Industry Participants
- Industry Participants
Decision Support Databases
- Decision Support Databases
About Frost & Sullivan
- Our Team
- Consulting Capabilities
This strategic analysis service provides detailed analysis of royalty issues and its affects on pharmaceutical products. The service in powerpoint format (approximately 75 slides) focuses not just only on the problems with royalty stacking, patents and problems with commercialisation of biotechnology but also on strategies for resolution of these problems.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | B484-01-00-00-00 |
Is Prebook | No |